Medcalf RL - Search Results

1

Tissue plasminogen activator does not alter development of acquired epilepsy.

Tan ML, Ng A, Pandher PS, Sashindranath M, Hamilton JA, Davis SM, O'Brien TJ, Medcalf RL, Yan B, Jones NC. Tan ML, et al. Among authors: medcalf rl. Epilepsia. 2012 Nov;53(11):1998-2004. doi: 10.1111/j.1528-1167.2012.03635.x. Epub 2012 Sep 7. Epilepsia. 2012. PMID: 22957978 Free article.

2

Cyclic AMP-dependent and -independent effects on tissue-type plasminogen activator activity in osteogenic sarcoma cells; evidence from phosphodiesterase inhibition and parathyroid hormone antagonists.

Allan EH, Hamilton JA, Medcalf RL, Kubota M, Martin TJ. Allan EH, et al. Among authors: medcalf rl. Biochim Biophys Acta. 1986 Sep 19;888(2):199-207. doi: 10.1016/0167-4889(86)90022-4. Biochim Biophys Acta. 1986. PMID: 3017447

3

Human synovial fibroblasts produce urokinase-type plasminogen activator.

Medcalf RL, Hamilton JA. Medcalf RL, et al. Arthritis Rheum. 1986 Nov;29(11):1397-401. doi: 10.1002/art.1780291113. Arthritis Rheum. 1986. PMID: 3096341

4

Suppression of urokinase-type plasminogen activator mRNA levels in human fibrosarcoma cells and synovial fibroblasts by anti-inflammatory glucocorticoids.

Medcalf RL, Richards RI, Crawford RJ, Hamilton JA. Medcalf RL, et al. EMBO J. 1986 Sep;5(9):2217-22. doi: 10.1002/j.1460-2075.1986.tb04487.x. EMBO J. 1986. PMID: 3780677 Free PMC article.

5

Control elements between -9.5 and -3.0 kb in the human tissue-type plasminogen activator gene promoter direct spatial and inducible expression to the murine brain.

Yu H, Schleuning WD, Michl M, Liberatore G, Tan SS, Medcalf RL. Yu H, et al. Among authors: medcalf rl. Eur J Neurosci. 2001 Sep;14(5):799-808. doi: 10.1046/j.0953-816x.2001.01700.x. Eur J Neurosci. 2001. PMID: 11576184

6

Plasminogen activator inhibitor type 2: a regulator of monocyte proliferation and differentiation.

Yu H, Maurer F, Medcalf RL. Yu H, et al. Among authors: medcalf rl. Blood. 2002 Apr 15;99(8):2810-8. doi: 10.1182/blood.v99.8.2810. Blood. 2002. PMID: 11929770 Free article.

7

Vampire bat salivary plasminogen activator (desmoteplase): a unique fibrinolytic enzyme that does not promote neurodegeneration.

Liberatore GT, Samson A, Bladin C, Schleuning WD, Medcalf RL. Liberatore GT, et al. Among authors: medcalf rl. Stroke. 2003 Feb;34(2):537-43. doi: 10.1161/01.str.0000049764.49162.76. Stroke. 2003. PMID: 12574572

8

Vampire bat salivary plasminogen activator (desmoteplase) inhibits tissue-type plasminogen activator-induced potentiation of excitotoxic injury.

Reddrop C, Moldrich RX, Beart PM, Farso M, Liberatore GT, Howells DW, Petersen KU, Schleuning WD, Medcalf RL. Reddrop C, et al. Among authors: medcalf rl. Stroke. 2005 Jun;36(6):1241-6. doi: 10.1161/01.STR.0000166050.84056.48. Epub 2005 May 5. Stroke. 2005. PMID: 15879331

9

Tissue-type plasminogen activator: a multifaceted modulator of neurotransmission and synaptic plasticity.

Samson AL, Medcalf RL. Samson AL, et al. Among authors: medcalf rl. Neuron. 2006 Jun 1;50(5):673-8. doi: 10.1016/j.neuron.2006.04.013. Neuron. 2006. PMID: 16731507 Free article. Review.

10

Two conserved regions within the tissue-type plasminogen activator gene promoter mediate regulation by brain-derived neurotrophic factor.

Daniel PB, Lux W, Samson AL, Schleuning WD, Niego B, Weiss TW, Tjärnlund-Wolf A, Medcalf RL. Daniel PB, et al. Among authors: medcalf rl. FEBS J. 2007 May;274(9):2411-23. doi: 10.1111/j.1742-4658.2007.05777.x. Epub 2007 Apr 5. FEBS J. 2007. PMID: 17419735 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

174 results

Search Page